Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials (2012)
- Authors:
- Autor USP: ANDRADE FILHO, MÁRIO DE CASTRO - ICMC
- Unidade: ICMC
- DOI: 10.1016/S1470-2045(11)70295-9
- Subjects: INFERÊNCIA BAYESIANA; ESTATÍSTICA APLICADA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Lancet Oncology
- ISSN: 1470-2045
- Volume/Número/Paginação/Ano: v. 13, n. 2, p. 189-195, Feb. 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
D'AMICO, Anthony Victor et al. Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials. The Lancet Oncology, v. 13, n. 2, p. 189-195, 2012Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(11)70295-9. Acesso em: 02 out. 2024. -
APA
D'Amico, A. V., Chen, M. -H., Castro, M. de, Loffredo, M., Lamb, D. S., Steigler, A., et al. (2012). Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials. The Lancet Oncology, 13( 2), 189-195. doi:10.1016/S1470-2045(11)70295-9 -
NLM
D'Amico AV, Chen M-H, Castro M de, Loffredo M, Lamb DS, Steigler A, Kantoff PW, Denham JW. Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials [Internet]. The Lancet Oncology. 2012 ; 13( 2): 189-195.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/S1470-2045(11)70295-9 -
Vancouver
D'Amico AV, Chen M-H, Castro M de, Loffredo M, Lamb DS, Steigler A, Kantoff PW, Denham JW. Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials [Internet]. The Lancet Oncology. 2012 ; 13( 2): 189-195.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/S1470-2045(11)70295-9 - Contribuições ao estudo de modelos com erros nas variáveis
- Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial
- The beta generalized gamma distribution
- Frailty models power variance function with cure fraction and latent risk factors negative binomial
- Maximum penalized likelihood inference in classical errors-in-variables model
- New estimation methods for the Grubbs model
- Robust inference in an heteroscedastic measurement error model
- Bayesian transformation models for multivariate survival data
- An alternative promotion time cure model with overdispersed number of competing causes: an application to melanoma data
- Influence assessment in an heteroscedastic errors-in-variables model
Informações sobre o DOI: 10.1016/S1470-2045(11)70295-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
